Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minimum remifentanil dose for pediatric intubation without neuromuscular blocker
PACTR201809879218534Recruiting
- Sponsor
- University of Pretoria
- Start
- Jul 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remifentanil in Not applicable (2 arms), sponsored by University of Pretoria. Primary endpoint: Minimum required remifentanil dose for intubation without neuromuscular blocker. Started Jul 2018; status: recruiting.
02
Drugs
remifentanil
03
Conditions
Not applicable
Beyond the preview
Go deeper on PACTR201809879218534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201809879218534.